From: Relative mortality in soft tissue sarcoma patients: a Danish population-based cohort study
 | N | RM, % | 95% CI |
---|---|---|---|
MFH | 300 | 28.0 | 21.4-35.2 |
Liposarcoma | 195 | 18.1 | 11.3-26.1 |
Leiomyosarcoma | 190 | 33.4 | 25.6-41.9 |
Dermatofibrosarcoma | 97 | 2.1 | 0.0-9.1 |
Synovial sarcoma | 79 | 46.4 | 35.4-58.5 |
MPNST | 78 | 52.4 | 40.8-64.5 |
Fibrosarcoma | 53 | 30.3 | 18.1-46.0 |
Rhabdomyosarcoma | 35 | 79.3 | 64.3-90.9 |
Angiosarcoma | 32 | 56.8 | 18.1-75.5 |
Extraosseous osteosarcoma | 25 | 48.6 | 27.6-71.4 |
PNET | 25 | 59.7 | 41.4-78.5 |
Epithelioid sarcoma | 21 | 27.9 | 13.2-52.4 |
Malignant hemangiopericytoma | 20 | 40.9 | 21.0-66.3 |
Extraosseous chondrosarcoma | 12 | 37.5 | 14.2-71.1 |
Unclassifiable | 48 | 52.3 | 36.1-68.8 |
Others | 36 | 31.5 | 17.3-50.6 |